Microencapsulation of cytarabine using poly(ethylene glycol)–poly(ε-caprolactone) diblock copolymers as surfactant agents

References

• Galmarini CM, Mackey JR, Dumontet C. (2002). Nucleosides analogues and nucleobases in cancer treatment. Lancet Oncol, 3:415–24.
   PubMed Web of Science ®Google Scholar
• Lindner LH, Ostermann H, Hiddemann W, Kiani A, Würfel M, Illmer T, . (2008). AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity. Int J Hematol, 88:381–6.
   PubMed Web of Science ®Google Scholar
• Mangravite LM, Badagnani I, Giacomini KM. (2003). Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol, 479:269–81.
   PubMed Web of Science ®Google Scholar
• Braess J, Pförtner J, Kern W, Hiddemann W, Schleyer E. (1999). Cytidine deaminase—the methodological relevance of AraC deamination for ex vivo experiments using cultured cell lines, fresh leukemic blasts, and normal bone marrow cells. Ann Hematol, 78:514–20.
   PubMed Web of Science ®Google Scholar
• Milano G, Chamorey AL, Thyss A. (2002). Clinical pharmacology of nucleoside analogues. Bull Cancer, 89:71–5.
   PubMed Web of Science ®Google Scholar
• Diab R, Degobert G, Hamoudeh M, Dumontet C, Fessi H. (2007). Nucleoside analogue delivery systems in cancer therapy. Expert Opin Drug Deliv, 4:513–31.
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Diab R, Fessi H, Dumontet C, Cuchet D. (2008). Paclitaxel-loaded microparticles for intratumoral administration via the TMT technique: Preparation, characterization, and preliminary antitumoral evaluation. Drug Dev Ind Pharm, 34:698–707.
   PubMed Web of Science ®Google Scholar
• Kang Y, Wu J, Yin G, Huang Z, Liao X, Yao Y, . (2008). Characterization and biological evaluation of paclitaxel-loaded poly(l-lactic acid) microparticles prepared by supercritical CO2. Langmuir, 24:7432–41.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 125:193–209.
   PubMed Web of Science ®Google Scholar
• Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL. (2007). Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel. Pharm Res, 24:1691–701.
   PubMed Web of Science ®Google Scholar
• Almond BA, Hadba AR, Freeman ST, Cuevas BJ, York AM, Detrisac CJ, . (2003). Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Control Release, 91:147–55.
   PubMed Web of Science ®Google Scholar
• Xie M, Zhou L, Hu T, Yao M. (2007). Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. Anticancer Drugs, 18:459–66.
   PubMed Web of Science ®Google Scholar
• Blanco MD, Gómez C, Olmo R, Muñiz E, Teijón JM. (2000). Chitosan microspheres in PLG films as devices for cytarabine release. Int J Pharm, 202:29–39.
   PubMed Web of Science ®Google Scholar
• Sastre RL, Olmo R, Teijón C, Muñíz E, Teijón JM, Blanco MD. (2007). 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers. Int J Pharm, 338:180–90.
   PubMed Web of Science ®Google Scholar
• Ustariz-Peyret C. (1999). Cephradin-plaga microspheres for sustained delivery to cattle. J Microencapsul, 16:181–94.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 57:171–85.
   PubMed Web of Science ®Google Scholar
• Pistel KF, Kissel T. (2000). Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul, 17:467–83.
   PubMed Web of Science ®Google Scholar
• Mandal TK, Shekleton M, Onyebueke E, Washington L, Penson T. (1996). Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine. J Microencapsul, 13:545–57.
   PubMed Web of Science ®Google Scholar
• Leo E, Brina B, Forni F, Vandelli M. (2004). In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int J Pharm, 278:133–41.
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, . (2007). Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 66:488–92.
   PubMed Web of Science ®Google Scholar
• Quellec P, Gref R, Perrin L, Dellacherie E, Sommer F, Verbavatz JM, . (1998). Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res, 42:45–54.
   PubMed Web of Science ®Google Scholar
• Vangeytea P, Gautiera S, Jérôme R. (2004). About the methods of preparation of poly(ethylene oxide)-b-poly(ε-caprolactone) nanoparticles in water: Analysis by dynamic light scattering. Colloids Surf A, 242:203–11.
   Web of Science ®Google Scholar
• Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. (1998). Stealth PLA–PEG nanoparticles as protein carriers for nasal administration. Pharm Res, 15:270–5.
   PubMed Web of Science ®Google Scholar
• Ha JH, Kim SH, Han SY. (1997). Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly (epsilon-caprolactone) and poly(ethylene glycol) macromer. J Control Release, 49:253–62.
   Web of Science ®Google Scholar
• Hachicha W, Kodjikian L, Fessi H. (2006). Preparation of vancomycin microparticles: Importance of preparation parameters. Int J Pharm, 324:176–84.
   PubMed Web of Science ®Google Scholar
• Coccoli V, Luciani A, Orsi S, Guarino V, Causa F, Netti PA. (2008). Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Manipulative Physiol Ther, 19:1703–11.
   Google Scholar
• Rawat A, Majumder QH, Ahsan F. (2008). Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluation. J Control Release, 128:224–32.
   PubMed Web of Science ®Google Scholar
• Gómez C, Blanco MD, Bernardo MV, Olmo R, Muñiz E, Teijón JM. (2004). Cytarabine release from comatrices of albumin microspheres in a poly(lactide–co-glycolide) film: In vitro and in vivo studies. Eur J Pharm Biopharm, 57:225–33.
   PubMed Web of Science ®Google Scholar
• Bogner A, Thollet G, Basset D, Jouneau PH, Gauthier C. (2005). Wet STEM: A new development in environmental SEM for imaging nano-objects included in a liquid phase. Ultramicroscopy, 104:290–301.
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Fessi H, Mehier H, Faraj AA, Canet-Soulas E. (2008). Dirhenium decacarbonyl-loaded PLLA nanoparticles: Influence of neutron irradiation and preliminary in vivo administration by the TMT technique. Int J Pharm, 348:125–36.
   PubMed Web of Science ®Google Scholar
• Kricheldorf HR, Kreiser-Saunders I. (2000). Polylactones 49: Bu4Sn-initiated polymerizations of 1-caprolactone. Polymer, 41:3957–63.
   Web of Science ®Google Scholar
• Hua C, Dong CM. (2007). Synthesis, characterization, effect of architecture on crystallization of biodegradable poly(ϵ-caprolactone)-b-poly(ethylene oxide) copolymers with different arms and nanoparticles thereof. J Biomed Mater Res, 82:689–700.
   Google Scholar
• Choi C, Chae SY, Kim TH, Kweon JK, Cho CS, Jang MK, . (2006). Synthesis and physicochemical characterization of amphiphilic block copolymer self-aggregates formed by poly(ethylene glycol)-block-poly(epsilon-caprolactone). J Appl Polym Sci, 99:3520–7.
   Web of Science ®Google Scholar
• Du ZX, Xu JT, Yang Y, Fan ZQ. (2007). Synthesis and characterization of poly(e-caprolactone)-bpoly(ethylene glycol) block copolymers prepared by a salicylaldimine-aluminum complex. J Appl Polym Sci, 105:771–6.
   Web of Science ®Google Scholar
• Huang MH, Li S, Hutmacher DW, Schantz JT, Vacanti CA, Braud C, . (2004). Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol). Inc J Biomed Mater Res A, 69:417–27.
   PubMed Web of Science ®Google Scholar
• Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F. (2005). Effect of surfactant HLB and different formulation variables on the properties of poly-d,l-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsul, 22:139–51.
   PubMed Web of Science ®Google Scholar
• Vila A, Sanchez A, Evora C, Soriano I, Vila Jato JL, Alonso MJ. (2004). PEG-PLA nanoparticles as carriers for nasal vaccine delivery. J Aerosol Med, 17:174–85.
   PubMedGoogle Scholar
• Stolnik S, Felumb NC, Heald CR, Garnett MC, IIlium L, Davis SS. (1997). Adsorption behaviour and conformation of selected poly(ethylene oxide) copolymers on the surface of a model colloidal drug carrier. Colloids Surf A Physicochem Eng Asp, 122:151–9.
   Web of Science ®Google Scholar
• Shen C, Guo S, Lu C. (2008). Degradation behaviors of monomethoxy poly(ethylene glycol)-b-poly(e-caprolactone) nanoparticles in aqueous solution. Polym Adv Technol, 19:66–72.
   Web of Science ®Google Scholar
• Shen C, Guo S, Lu C. (2007). Degradation behaviors of star-shaped poly(ethylene glycol)epoly (3-caprolactone) nanoparticles in aqueous solution. Polym Degrad Stab, 92:1891–8.
   Web of Science ®Google Scholar
• Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, . (2001). PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release, 71:203–11.
   PubMed Web of Science ®Google Scholar
• Morikawa MA, Yoshihara M, Endo T, Kimizuka N. (2005). Alpha-helical polypeptide microcapsules formed by emulsion-templated self-assembly. Chem Eur J, 11:1574–8.
   PubMed Web of Science ®Google Scholar
• Lecaroz C, Gamazo C, Renedo MJ, Blanco-Prieto MJ. (2006). Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J Microencapsul, 23:782–92.
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. (2007). Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm, 334:137–48.
   PubMed Web of Science ®Google Scholar
• Bitz C, Doelker E. (1996). Influence of the preparation method on residual solvents biodegradable microspheres. Int J Pharm, 131:171–81.
   Web of Science ®Google Scholar
• O'Donnell PB, McGinity JW. (1997). Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev, 28:25–42.
   PubMed Web of Science ®Google Scholar
• Sipos P, Csoka I, Srcic S, Pintye-Hodi K, Eros I. (2005). Influence of preparation conditions on the properties of Eudragit microspheres produced by a double emulsion method. Drug Dev Res, 64:41–54.
   Web of Science ®Google Scholar
• Xie J, Wang CH. (2007). Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor Cone-Jet mode. Biotechnol Bioeng, 97:1278–90.
   PubMed Web of Science ®Google Scholar
• Shah PP, Mashru RC, Rane YM, Thakkar A. (2008). Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS PharmSciTech, 9:377–89.
   PubMed Web of Science ®Google Scholar
• Chawla JS, Amiji MM. (2002). Biodegradable poly(o-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int J Pharm, 249:127–38.
   PubMed Web of Science ®Google Scholar
• Jeong JC, Lee J, Cho K. (2003). Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres. J Control Release, 92:249–58.
   PubMed Web of Science ®Google Scholar
• Della Porta G, Reverchon E. (2008). Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Biotechnol Bioeng, 100:1020–33.
   PubMed Web of Science ®Google Scholar
• Park HY, Oh KS, Koo HM, Cho SH, Chung SJ, Lim YT, . (2008). Heparin-immobilized pluronic/PVA composite microparticles for the sustained delivery of ionic drug. J Microencapsul, 25:106–10.
   PubMed Web of Science ®Google Scholar
• Hombreiro Pérez M, Zinutti C, Lamprecht A, Ubrich N, Astier A, Hoffman M, . (2000). The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release, 65:429–38.
   PubMed Web of Science ®Google Scholar
• Poletto FS, Jäger E, Ré MI, Guterres SS, Pohlmann AR. (2007). Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs. Int J Pharm, 345:70–80.
   PubMed Web of Science ®Google Scholar
• Wechter WJ, Johnson MA, Hall CM, Warner DT, Berger AE, Wenzel AH, . (1975). Ara-cytidine acylates. Use of drug design predictors in structure-activity relationship correlation. J Med Chem, 18:339–44.
   PubMed Web of Science ®Google Scholar
• Sun X, Duan YR, He Q, Lu J, Zhang ZR. (2005). PELGE nanoparticles as new carriers for the delivery of plasmid DNA. Chem Pharm Bull, 53:599–603.
   Google Scholar
• Dorati R, Genta I, Tomasi C, Modena T, Colonna C, Pavanetto F, . (2008). Polyethylenglycol-co-poly-d,l-lactide copolymer based microspheres: Preparation, characterization and delivery of a model protein. J Microencapsul, 25:330–8.
   PubMed Web of Science ®Google Scholar
• Fernández-Carballido A, Pastoriza P, Barcia E, Montejo C, Negro S. (2008). PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies. Int J Pharm, 352:50–7.
   PubMed Web of Science ®Google Scholar
• Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG. (2008). In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res, 25:2370–8.
   PubMed Web of Science ®Google Scholar
• Klose D, Siepmann F, Elkharraz K, Krenzlin S, Siepmann J. (2006). How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int J Pharm, 314:198–206.
   PubMed Web of Science ®Google Scholar
• Hombreiro-Pérez M, Siepmann J, Zinutti C, Lamprecht A, Ubrich N, Hoffman M, . (2003). Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J Control Release, 88:413–28.
   PubMed Web of Science ®Google Scholar